Haymaker Acquisition Corp. III
Partners in Consumer-Related Business
Haymaker Acquisition Corp. III (“Haymaker III”, “We” or “Us”), a $317.5 million special purpose acquisition company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Our management team was led by Steven J. Heyer, our Chief Executive Officer and Executive Chairman, Andrew R. Heyer, our President, and Christopher Bradley, our Chief Financial Officer and M&A Lead. The combined experience of our officers includes Haymaker Acquisition Corp. I, a special purpose acquisition company which completed a $330 million initial public offering in October 2017 and completed its initial business combination in March 2019; and Haymaker Acquisition Corp. II, a special purpose acquisition company which completed a $400 million initial public offering in June 2019 and completed its initial business combination in December 2020.
Haymaker Acquisition Corp. III Completes Business Combination
On May 26, 2022, Haymaker III and biote LLC (“Biote”), a leading health and wellness company focusing on customized hormone therapies, announced that they had satisfied all closing requirements for their business combination. Under the terms of the agreement, Haymaker III and Biote combined under the new holding company, biote Corp. (“the Company”), in a business combination involving $672 million in total consideration.
Consistent with the terms of the business combination, Haymaker III and Biote combined under the new holding company, biote Corp, whose common shares are listed under the Nasdaq Stock Market under the symbol “BTMD.” The warrants to purchase biote Corp common shares were subsequently exchanged into common shares of BTMD.